tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ESPR Stock Latest News

Esperion reaches settlement agreement with Micro Labs
The FlyEsperion reaches settlement agreement with Micro Labs
13d ago
ESPR
Esperion’s Strategic Expansion and Promising Financial Outlook Earns Buy Rating
PremiumRatings
Esperion’s Strategic Expansion and Promising Financial Outlook Earns Buy Rating
17d ago
ESPR
Esperion enters license and distribution agreement with HLS Therapeutics
PremiumThe Fly
Esperion enters license and distribution agreement with HLS Therapeutics
17d ago
ESPR
Esperion Therapeutics Reports Mixed Q1 2025 Results
PremiumCompany Announcements
Esperion Therapeutics Reports Mixed Q1 2025 Results
18d ago
ESPR
Esperion Therapeutics Reports Strong Q1 2025 Earnings
PremiumCompany Announcements
Esperion Therapeutics Reports Strong Q1 2025 Earnings
18d ago
ESPR
Esperion’s Growth Potential: Buy Rating Affirmed Amid Strong Sales and Strategic Advances
PremiumRatingsEsperion’s Growth Potential: Buy Rating Affirmed Amid Strong Sales and Strategic Advances
18d ago
ESPR
Esperion Therapeutics (ESPR) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Esperion Therapeutics (ESPR) Q1 Earnings Cheat Sheet
21d ago
ESPR
Esperion’s Strategic Expansion and ACLY Innovation Drive Buy Rating
Premium
Ratings
Esperion’s Strategic Expansion and ACLY Innovation Drive Buy Rating
30d ago
ESPR
Esperion’s Strategic Growth and Product Expansion Drive Buy Rating
PremiumRatings
Esperion’s Strategic Growth and Product Expansion Drive Buy Rating
1M ago
ESPR
Esperion announces plans for new research on lead development candidates
PremiumThe Fly
Esperion announces plans for new research on lead development candidates
1M ago
ESPR
Esperion to host R&D Day to highlight cardiometabolic pipeline
PremiumThe Fly
Esperion to host R&D Day to highlight cardiometabolic pipeline
1M ago
ESPR
Esperion Appoints Robert E. Hoffman as New Director
PremiumCompany Announcements
Esperion Appoints Robert E. Hoffman as New Director
2M ago
8K
ESPR
Esperion appoints Hoffman to board of directors
PremiumThe FlyEsperion appoints Hoffman to board of directors
2M ago
ESPR
Esperion’s Strategic Growth: Phase 3 Expansion and Patent Protection Boost Valuation
Premium
Ratings
Esperion’s Strategic Growth: Phase 3 Expansion and Patent Protection Boost Valuation
2M ago
ESPR
Esperion aligns with U.S. FDA to initiate Phase 3 trials of bempedoic acid
Premium
The Fly
Esperion aligns with U.S. FDA to initiate Phase 3 trials of bempedoic acid
2M ago
ESPR
Esperion’s Promising Future: Strategic Partnerships and Product Innovations Drive Buy Rating
PremiumRatings
Esperion’s Promising Future: Strategic Partnerships and Product Innovations Drive Buy Rating
3M ago
ESPR
Sell Rating for Esperion Amidst US Market Underperformance and Competitive Pressures
PremiumRatings
Sell Rating for Esperion Amidst US Market Underperformance and Competitive Pressures
3M ago
ESPR
Esperion Therapeutics Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Esperion Therapeutics Reports Strong Revenue Growth in 2024
3M ago
ESPR
Esperion Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Esperion Therapeutics’ Earnings Call: Growth Amid Challenges
3M ago
ESPR
Esperion’s Growth Potential Highlighted by Global Expansion and Strategic Partnerships
PremiumRatingsEsperion’s Growth Potential Highlighted by Global Expansion and Strategic Partnerships
3M ago
ESPR
Esperion’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
Premium
Ratings
Esperion’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
3M ago
ESPR
Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
Premium
The Fly
Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
3M ago
LH
BBY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >